Structural insight into multistage inhibition of CRISPR-Cas12a by AcrVA4

Ruchao Peng,Zhiteng Li,Ying Xu,Shaoshuai He,Qi Peng,Lian-Ao Wu,Ying Wu,Jianxun Qi,Peiyi Wang,Yi Shi,George F Gao,Lian-ao Wu,George F. Gao
DOI: https://doi.org/10.1073/pnas.1909400116
IF: 11.1
2019-08-29
Proceedings of the National Academy of Sciences
Abstract:Significance Bacteriophage encodes anti-CRISPR (Acr) proteins to inactivate host bacterial CRISPR-Cas systems. These Acrs are also found in bacteria to avoid self-targeting autoimmunity. So far, quite a few Acrs targeting type I and II CRISPR-Cas systems have been well characterized. In contrast, the Acrs inhibiting type V systems remain poorly understood. Both type II (Cas9) and V (Cas12a) CRISPR-Cas systems have been harnessed as powerful tools for genome editing and the latter showed even better efficiency and accuracy. In this work, we report a comprehensive mechanistic insight into a unique multistage inhibitor, AcrVA4, blocking CRISPR-Cas12a activity, different from other characterized single-stage targeting Acrs. This represents a sophisticated mechanism for CRISPR-Cas inhibition and provides clues for developing regulatory tools for genome editing.
multidisciplinary sciences
What problem does this paper attempt to address?